Peter Tanghe, MD - Medicare Emergency Medicine in Bloomington, MN

Peter Tanghe, MD is a medicare enrolled "Emergency Medicine" physician in Bloomington, Minnesota. He graduated from medical school in 2000 and has 24 years of diverse experience with area of expertise as Emergency Medicine. He is a member of the group practice Emergency Physicians Professional Association, North Memorial Health Care and his current practice location is 4300 Marketpointe Dr Ste 100, Bloomington, Minnesota. You can reach out to his office (for appointments etc.) via phone at (952) 835-9880.

Peter Tanghe is licensed to practice in Minnesota (license number 46126) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1922075183.

Contact Information

Peter Tanghe, MD
4300 Marketpointe Dr Ste 100,
Bloomington, MN 55435
(952) 835-9880
(952) 857-1554



Physician's Profile

Full NamePeter Tanghe
GenderMale
SpecialityEmergency Medicine
Experience24 Years
Location4300 Marketpointe Dr Ste 100, Bloomington, Minnesota
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Peter Tanghe graduated from medical school in 2000
  NPI Data:
  • NPI Number: 1922075183
  • Provider Enumeration Date: 03/07/2006
  • Last Update Date: 06/14/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 1850285685
  • Enrollment ID: I20040211001084

Medical Identifiers

Medical identifiers for Peter Tanghe such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1922075183NPI-NPPES
46126OtherMNMEDICAL LICENSE
908142900MedicaidMN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine 46126 (Minnesota)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
North Memorial HealthRobbinsdale, MNHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Emergency Physicians Professional Association9537072657205
North Memorial Health Care0042123028483

News Archive

Six-minute walking distance test effectively determines disease severity in COPD

The six-minute walking distance test, a test that measures a patient's ability to tolerate exercise and physical activity, is an effective tool for understanding disease severity in patients with chronic obstructive pulmonary disease, according to a three-year global study of patients with COPD sponsored by drug manufacturer GlaxoSmithKline.

New center for advanced emergency response to inaugurate on Jan. 6 at RUMC

The doors to the new, state-of-the-art emergency center at 1653 W. Congress Parkway will be the first to "open in the new hospital building at Rush University Medical Center at 6 a.m. CT on Friday, Jan. 6. Rush's current emergency department will close early Friday morning when the department goes on bypass during the move to the new facility.

New data on why aging brain is less resilient and less capable of learning from life experiences

Researchers at Mount Sinai School of Medicine have published new data on why the aging brain is less resilient and less capable of learning from life experiences. The findings provide further insight into the cognitive decline associated with aging and neurodegenerative diseases like Alzheimer's. The study is published in the May 25 issue of the Journal of Neuroscience.

GeoBlue launches first iPhone app for quality healthcare services

GeoBlue, a leader and innovator serving the medical needs of expatriates and world travelers, announced today that it has launched the first iPhone application for finding and paying for quality healthcare services all around the world. GeoBlue Mobile is now available in the iTunes App Store for downloading onto iPhones, iPads and iPod touches.

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control[1]. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Peter Tanghe allows following entities to bill medicare on his behalf.
Entity NameEmergency Physicians Professional Association
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1801871934
PECOS PAC ID: 9537072657
Enrollment ID: O20031106000068

News Archive

Six-minute walking distance test effectively determines disease severity in COPD

The six-minute walking distance test, a test that measures a patient's ability to tolerate exercise and physical activity, is an effective tool for understanding disease severity in patients with chronic obstructive pulmonary disease, according to a three-year global study of patients with COPD sponsored by drug manufacturer GlaxoSmithKline.

New center for advanced emergency response to inaugurate on Jan. 6 at RUMC

The doors to the new, state-of-the-art emergency center at 1653 W. Congress Parkway will be the first to "open in the new hospital building at Rush University Medical Center at 6 a.m. CT on Friday, Jan. 6. Rush's current emergency department will close early Friday morning when the department goes on bypass during the move to the new facility.

New data on why aging brain is less resilient and less capable of learning from life experiences

Researchers at Mount Sinai School of Medicine have published new data on why the aging brain is less resilient and less capable of learning from life experiences. The findings provide further insight into the cognitive decline associated with aging and neurodegenerative diseases like Alzheimer's. The study is published in the May 25 issue of the Journal of Neuroscience.

GeoBlue launches first iPhone app for quality healthcare services

GeoBlue, a leader and innovator serving the medical needs of expatriates and world travelers, announced today that it has launched the first iPhone application for finding and paying for quality healthcare services all around the world. GeoBlue Mobile is now available in the iTunes App Store for downloading onto iPhones, iPads and iPod touches.

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control[1]. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

Read more Medical News

› Verified 4 days ago

Entity NameHealtheast Woodwinds Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1356309322
PECOS PAC ID: 9638082563
Enrollment ID: O20031107000110

News Archive

Six-minute walking distance test effectively determines disease severity in COPD

The six-minute walking distance test, a test that measures a patient's ability to tolerate exercise and physical activity, is an effective tool for understanding disease severity in patients with chronic obstructive pulmonary disease, according to a three-year global study of patients with COPD sponsored by drug manufacturer GlaxoSmithKline.

New center for advanced emergency response to inaugurate on Jan. 6 at RUMC

The doors to the new, state-of-the-art emergency center at 1653 W. Congress Parkway will be the first to "open in the new hospital building at Rush University Medical Center at 6 a.m. CT on Friday, Jan. 6. Rush's current emergency department will close early Friday morning when the department goes on bypass during the move to the new facility.

New data on why aging brain is less resilient and less capable of learning from life experiences

Researchers at Mount Sinai School of Medicine have published new data on why the aging brain is less resilient and less capable of learning from life experiences. The findings provide further insight into the cognitive decline associated with aging and neurodegenerative diseases like Alzheimer's. The study is published in the May 25 issue of the Journal of Neuroscience.

GeoBlue launches first iPhone app for quality healthcare services

GeoBlue, a leader and innovator serving the medical needs of expatriates and world travelers, announced today that it has launched the first iPhone application for finding and paying for quality healthcare services all around the world. GeoBlue Mobile is now available in the iTunes App Store for downloading onto iPhones, iPads and iPod touches.

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control[1]. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

Read more Medical News

› Verified 4 days ago

Entity NameHealtheast St Joseph's Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1134186273
PECOS PAC ID: 2365348869
Enrollment ID: O20031208000245

News Archive

Six-minute walking distance test effectively determines disease severity in COPD

The six-minute walking distance test, a test that measures a patient's ability to tolerate exercise and physical activity, is an effective tool for understanding disease severity in patients with chronic obstructive pulmonary disease, according to a three-year global study of patients with COPD sponsored by drug manufacturer GlaxoSmithKline.

New center for advanced emergency response to inaugurate on Jan. 6 at RUMC

The doors to the new, state-of-the-art emergency center at 1653 W. Congress Parkway will be the first to "open in the new hospital building at Rush University Medical Center at 6 a.m. CT on Friday, Jan. 6. Rush's current emergency department will close early Friday morning when the department goes on bypass during the move to the new facility.

New data on why aging brain is less resilient and less capable of learning from life experiences

Researchers at Mount Sinai School of Medicine have published new data on why the aging brain is less resilient and less capable of learning from life experiences. The findings provide further insight into the cognitive decline associated with aging and neurodegenerative diseases like Alzheimer's. The study is published in the May 25 issue of the Journal of Neuroscience.

GeoBlue launches first iPhone app for quality healthcare services

GeoBlue, a leader and innovator serving the medical needs of expatriates and world travelers, announced today that it has launched the first iPhone application for finding and paying for quality healthcare services all around the world. GeoBlue Mobile is now available in the iTunes App Store for downloading onto iPhones, iPads and iPod touches.

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control[1]. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

Read more Medical News

› Verified 4 days ago

Entity NameHealtheast St John's Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1447218482
PECOS PAC ID: 9234035742
Enrollment ID: O20031208000320

News Archive

Six-minute walking distance test effectively determines disease severity in COPD

The six-minute walking distance test, a test that measures a patient's ability to tolerate exercise and physical activity, is an effective tool for understanding disease severity in patients with chronic obstructive pulmonary disease, according to a three-year global study of patients with COPD sponsored by drug manufacturer GlaxoSmithKline.

New center for advanced emergency response to inaugurate on Jan. 6 at RUMC

The doors to the new, state-of-the-art emergency center at 1653 W. Congress Parkway will be the first to "open in the new hospital building at Rush University Medical Center at 6 a.m. CT on Friday, Jan. 6. Rush's current emergency department will close early Friday morning when the department goes on bypass during the move to the new facility.

New data on why aging brain is less resilient and less capable of learning from life experiences

Researchers at Mount Sinai School of Medicine have published new data on why the aging brain is less resilient and less capable of learning from life experiences. The findings provide further insight into the cognitive decline associated with aging and neurodegenerative diseases like Alzheimer's. The study is published in the May 25 issue of the Journal of Neuroscience.

GeoBlue launches first iPhone app for quality healthcare services

GeoBlue, a leader and innovator serving the medical needs of expatriates and world travelers, announced today that it has launched the first iPhone application for finding and paying for quality healthcare services all around the world. GeoBlue Mobile is now available in the iTunes App Store for downloading onto iPhones, iPads and iPod touches.

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control[1]. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

Read more Medical News

› Verified 4 days ago

Entity NameNorth Memorial Health Care
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1851344907
PECOS PAC ID: 0042123028
Enrollment ID: O20040122000470

News Archive

Six-minute walking distance test effectively determines disease severity in COPD

The six-minute walking distance test, a test that measures a patient's ability to tolerate exercise and physical activity, is an effective tool for understanding disease severity in patients with chronic obstructive pulmonary disease, according to a three-year global study of patients with COPD sponsored by drug manufacturer GlaxoSmithKline.

New center for advanced emergency response to inaugurate on Jan. 6 at RUMC

The doors to the new, state-of-the-art emergency center at 1653 W. Congress Parkway will be the first to "open in the new hospital building at Rush University Medical Center at 6 a.m. CT on Friday, Jan. 6. Rush's current emergency department will close early Friday morning when the department goes on bypass during the move to the new facility.

New data on why aging brain is less resilient and less capable of learning from life experiences

Researchers at Mount Sinai School of Medicine have published new data on why the aging brain is less resilient and less capable of learning from life experiences. The findings provide further insight into the cognitive decline associated with aging and neurodegenerative diseases like Alzheimer's. The study is published in the May 25 issue of the Journal of Neuroscience.

GeoBlue launches first iPhone app for quality healthcare services

GeoBlue, a leader and innovator serving the medical needs of expatriates and world travelers, announced today that it has launched the first iPhone application for finding and paying for quality healthcare services all around the world. GeoBlue Mobile is now available in the iTunes App Store for downloading onto iPhones, iPads and iPod touches.

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control[1]. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Peter Tanghe is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Peter Tanghe, MD
4300 Marketpointe Dr Ste 100,
Bloomington, MN 55435-5435

Ph: (952) 835-9880
Peter Tanghe, MD
4300 Marketpointe Dr Ste 100,
Bloomington, MN 55435

Ph: (952) 835-9880

News Archive

Six-minute walking distance test effectively determines disease severity in COPD

The six-minute walking distance test, a test that measures a patient's ability to tolerate exercise and physical activity, is an effective tool for understanding disease severity in patients with chronic obstructive pulmonary disease, according to a three-year global study of patients with COPD sponsored by drug manufacturer GlaxoSmithKline.

New center for advanced emergency response to inaugurate on Jan. 6 at RUMC

The doors to the new, state-of-the-art emergency center at 1653 W. Congress Parkway will be the first to "open in the new hospital building at Rush University Medical Center at 6 a.m. CT on Friday, Jan. 6. Rush's current emergency department will close early Friday morning when the department goes on bypass during the move to the new facility.

New data on why aging brain is less resilient and less capable of learning from life experiences

Researchers at Mount Sinai School of Medicine have published new data on why the aging brain is less resilient and less capable of learning from life experiences. The findings provide further insight into the cognitive decline associated with aging and neurodegenerative diseases like Alzheimer's. The study is published in the May 25 issue of the Journal of Neuroscience.

GeoBlue launches first iPhone app for quality healthcare services

GeoBlue, a leader and innovator serving the medical needs of expatriates and world travelers, announced today that it has launched the first iPhone application for finding and paying for quality healthcare services all around the world. GeoBlue Mobile is now available in the iTunes App Store for downloading onto iPhones, iPads and iPod touches.

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control[1]. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

Read more News

› Verified 4 days ago


Emergency Medicine Doctors in Bloomington, MN

Rebecca Lynn Meyer, M.D.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435
Phone: 952-835-9880    
Dr. Holly Lynn Schrupp Berg, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435
Phone: 952-835-9880    Fax: 952-857-1554
Andrew H Bauer, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435
Phone: 952-835-9880    Fax: 952-857-1554
Laura Kuhlman,
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435
Phone: 952-835-9880    
Elisabeth Marycke Vreede Greenberg,
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435
Phone: 952-835-9880    Fax: 952-857-1554
Leonardo A Saavedra, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435
Phone: 952-835-9880    Fax: 952-857-1554
Dr. Ferris Yeh, DO
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435
Phone: 952-835-9880    Fax: 952-857-1554

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.